Transplantation cardiaque: prevention secondaire

[en] Cardiac transplantation is the treatment of choice for refractory heart failure. An immunosuppressive therapy must be given in the perioperative course to avoid graft rejection. In this article, we review the main classes of immunosuppressive agents (calcineurin inhibitors, anti-metabolities, corticoids) and their side effects. The general preventive measures and the different kinds of rejection (hyperacute, acute vascular, acute cellular and chronical) are discussed. The current bacterial, protozoarian, mycotic and viral infections are described. We finish with the risk of cancer, mainly skin tumours and non-Hodgkinian lymphomas.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Nellessen, Eric ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie

Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques

Demoulin, J. C.

PIERARD, Luc ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie

Language :

French

Title :

Transplantation cardiaque: prevention secondaire

Alternative titles :

[en] Heart Transplantation: Secondary Prevention

Publication date :

June 2003

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

429-34

Peer reviewed :

Peer reviewed

Available on ORBi :

since 10 May 2014

Statistics

Number of views

128 (5 by ULiège)

Number of downloads

291 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Nellessen E, Mélon P, Piérard LA. - Prise en charge de l'insuffisance cardiaque en 2002. Med Hyg, 2002, 60, 1496-1502.
Gambino A, Testolin L, Gerosa G, et al. - New trends in heart transplantation. Transplant Proc, 2001, 33, 3536-3538.
Bangratz S, Olivier D. - Les complications en transplantation cardiaque: diagnostic et traitement. Presse Med, 2001, 30-24, Cahier 2: 8-12.
Kirklin JK, Naftel DC, Levine TB, et al. - Cytomegalovirus after heart transplantation. Risk factors for infection and death. A multiinstitutional study. J Heart Lung Transplant, 1994, 13, 394-404.
Halloran PF, Kung L, Noujaim J. - Calcineurin and the biological effect of cyclosporin and tacrolimus. Transplant Proc, 1998, 30, 2167-2170.
Ensley RD, Bristow MR, Taylor DO, et al. - The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients. Transplantation, 1993, 56, 75-82.
Kobashigawa JA, Katznelson A, Laks H, et al. - Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med, 1995, 333, 621-627.
Baumgartner WA, Reitz B, Kasper E, Theodore J. Heart and lung transplantation. Second Edition. Saunders Company, 2002, 427-429.
Nora JJ, Cooley DA, Fernbach DJ, et al. - Rejection of the transplanted human heart. N Engl J Med, 1969, 280, 1079-1086.
Stinson EB, Dong EJ, Bieber CP, et al. - Cardiac transplantation in man. Early rejection. JAMA, 1969, 207, 2233-2247.
Deng MC. - Cardiac transplantation. Heart, 2002, 87, 177-184.
Billingham ME, Lary NR, Hammond ME, et al. - A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant, 1990, 9, 587-593.
Smith JA, Ribakove GH, Hunt SA, et al. - Heart retransplantation: The 25-year experience at a single institution. J Heart Lung Transplant, 1995, 14, 832-839.
Miller LW, Naftel DC, Bourge RC, et al. - Infection after heart transplantation: A multiinstitutional study. Cardiac Transplant Research Database Group. J Heart Lung Transplant, 1994, 13, 381-393.
De Maria R, Minoli L, Parolini M, et al. - Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. J Heart Lung Transplant, 1996, 15, 124-135.
Ho M. - Epidemiology of cytomegalovirus infection. Rev Infect Dis, 1990, 12 (Suppl), S701.
Loebe M, Schuler S, Zais O, et al. - Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant. 1990, 9, 707-711.
Thomas JA, Crawford DH, Burke M. - Clinicopathological implications of Epstein-Barr virus related B cell lymphoma in immunocompromised patients. J Clin Pathol, 1995, 48, 287-290.